Literature DB >> 22382730

Physicochemical investigations and stability studies of amorphous gliclazide.

Shital Jondhale1, Satish Bhise, Yogesh Pore.   

Abstract

Gliclazide (GLI), a poorly water-soluble antidiabetic, was transformed into a glassy state by melt quench technique in order to improve its physicochemical properties. Chemical stability of GLI during formation of glass was assessed by monitoring thin-layer chromatography, and an existence of amorphous form was confirmed by differential scanning calorimetry and X-ray powder diffractometry. The glass transition occurred at 67.5°C. The amorphous material thus generated was examined for its in vitro dissolution performance in phosphate buffer (pH 6.8). Surprisingly, amorphous GLI did not perform well and was unable to improve the dissolution characteristics compared to pure drug over entire period of dissolution studies. These unexpected results might be due to the formation of a cohesive supercooled liquid state and structural relaxation of amorphous form toward the supercooled liquid region which indicated functional inability of amorphous GLI from stability point of view. Hence, stabilization of amorphous GLI was attempted by elevation of T(g) via formation of solid dispersion systems involving comprehensive antiplasticizing as well as surface adsorption mechanisms. The binary and ternary amorphous dispersions prepared with polyvinylpyrrolidone K30 (as antiplasticizer for elevation of T (g)) and Aerosil 200® and/or Sylysia® 350 (as adsorbent) in the ratio of 1:1:1 (w/w) using kneading and spray-drying techniques demonstrated significant enhancement in rate and extent of dissolution of drug initially. During accelerated stability studies, ternary systems showed no significant reduction in drug dissolution performance over a period of 3 months indicating excellent stabilization of amorphous GLI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22382730      PMCID: PMC3364379          DOI: 10.1208/s12249-012-9760-0

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  35 in total

Review 1.  Amorphous pharmaceutical solids: preparation, characterization and stabilization.

Authors:  L Yu
Journal:  Adv Drug Deliv Rev       Date:  2001-05-16       Impact factor: 15.470

Review 2.  Physics of amorphous solids.

Authors:  Lori R Hilden; Kenneth R Morris
Journal:  J Pharm Sci       Date:  2004-01       Impact factor: 3.534

3.  Influence of particle design on oral absorption of poorly water-soluble drug in a silica particle-supercritical fluid system.

Authors:  Hiroshi Miura; Makoto Kanebako; Hiroyuki Shirai; Hiroshi Nakao; Toshio Inagi; Katsuhide Terada
Journal:  Chem Pharm Bull (Tokyo)       Date:  2011       Impact factor: 1.645

4.  Moisture-dependent crystallization of amorphous lamotrigine mesylate.

Authors:  E Schmitt; C W Davis; S T Long
Journal:  J Pharm Sci       Date:  1996-11       Impact factor: 3.534

5.  Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying method.

Authors:  Hirofumi Takeuchi; Shinsuke Nagira; Hiromitsu Yamamoto; Yoshiaki Kawashima
Journal:  Int J Pharm       Date:  2005-04-11       Impact factor: 5.875

Review 6.  Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus.

Authors:  K J Palmer; R N Brogden
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

7.  Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.

Authors:  S Sethia; E Squillante
Journal:  Int J Pharm       Date:  2004-03-19       Impact factor: 5.875

Review 8.  Comparison of efficacy, secondary failure rate, and complications of sulfonylureas.

Authors:  A D Harrower
Journal:  J Diabetes Complications       Date:  1994 Oct-Dec       Impact factor: 2.852

9.  Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.

Authors:  B C Hancock; S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

10.  Effect of moisture on polyvinylpyrrolidone in accelerated stability testing.

Authors:  Shaun Fitzpatrick; James F McCabe; Catherine R Petts; Steven W Booth
Journal:  Int J Pharm       Date:  2002-10-10       Impact factor: 5.875

View more
  6 in total

1.  Studies on tolfenamic acid-chitosan intermolecular interactions: effect of pH, polymer concentration and molecular weight.

Authors:  Sofia Ahmed; Muhammad Ali Sheraz; Ihtesham Ur Rehman
Journal:  AAPS PharmSciTech       Date:  2013-04-27       Impact factor: 3.246

2.  Screening of Sacrificial Excipients for Arresting Devitrification of Itraconazole from Solid Dispersion.

Authors:  Bhargavi M Patel; Mukesh C Gohel; Vaishali T Thakkar; Lalji H Baldaniya; Ruby R Christian; Tejal R Gandhi
Journal:  Turk J Pharm Sci       Date:  2019-03-27

3.  Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles.

Authors:  Yan-rong Jiang; Zhen-hai Zhang; Qi-yuan Liu; Shao-ying Hu; Xiao-yun Chen; Xiao-bin Jia
Journal:  Int J Nanomedicine       Date:  2013-06-25

4.  Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ.

Authors:  Mehran Mesgari Abbasi; Hadi Valizadeh; Hamed Hamishehkar; Parvin Zakeri-Milani
Journal:  Res Pharm Sci       Date:  2016 May-Jun

Review 5.  The Need for Restructuring the Disordered Science of Amorphous Drug Formulations.

Authors:  Khadijah Edueng; Denny Mahlin; Christel A S Bergström
Journal:  Pharm Res       Date:  2017-05-18       Impact factor: 4.200

6.  Development of a gliclazide ionic liquid and its mesoporous silica particles: an effective formulation strategy to improve oral absorption properties.

Authors:  Bijian Zhou; Dan Teng; Jinghui Li; Yanhong Zhang; Minghui Qi; Minghuang Hong; Guo-Bin Ren
Journal:  RSC Adv       Date:  2022-01-05       Impact factor: 3.361

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.